ArticleThe Lancet. Global health2025
Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older.
Article in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Subtypes of pre-diabetes in rural adolescent girls from India (DERVAN-11).BMJ open diabetes research & care · 2026Article
- Association of diet composition and meal intervals with short-term glycemic control and glycemic variability among type 2 diabetes mellitus patients.BMC endocrine disorders · 2026Observational
- Why HbA1c remains the pragmatic choice for monitoring in India's public health system.The Lancet regional health. Southeast Asia · 2026Article
- Prevalence and Determinants of Type 2 Diabetes Mellitus in a North Indian Population: a Community-Based Cross-Sectional Study.Maedica · 2026Article
- The limitations and fallacies of relying on glycosylated hemoglobin for diagnosing and monitoring diabetes in Indian populations.The Lancet regional health. Southeast Asia · 2026Review
- Prevalence and factors associated with prediabetes among older adults in India: evidence from a national survey.Frontiers in public health · 2026Article
- Association of sleep quality and glycemic variability among South Indian rural patients with Type-2 diabetes mellitus.Metabolism open · 2025Article
- Prevalence of non-communicable disease risk factors and chronic conditions among middle-aged and older adults in extreme poverty: a nationally representative cross-sectional study in India.The Lancet. Global health · 2025Article
- Immigration, acculturation, and diabetes: A comparative study of diabetes prevalence among Asian Indian immigrants living in the United States and native-born populations in India and the United States.SSM - population health · 2025Article
- Diabetes and cognitive health in India: a nationally representative survey of adults aged 45 years and older.BMJ open · 2025Article
- National Estimates of the Adult Diabetes Care Continuum in India, 2019-2021.JAMA internal medicine · 2023Article
- A Strategic Research Framework for Defeating Diabetes in India: A 21st-Century Agenda.Journal of the Indian Institute of Science · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundIndia is a country of 1·4 billion people that contributes to much of the global diabetes burden. Updated evidence on the state of the diabetes epidemic among middle-aged and older adults is imperative given that the risk of diabetes increases with age and that clinical and public health interventions can prevent diabetes complications. We aimed to estimate the prevalence, awareness, treatment, and control of diabetes in a nationally representative and state-representative sample of Indians aged 45 years and older.
methodsWe conducted a cross-sectional, nationally representative survey of adults in India aged 45 years and older and their spouses from 2017 to 2019. Our sample included 57 810 individuals and their spouses from 36 states and union territories, reflecting a representative sample of India as a nation and of each state and union territory. Participants had available data on glycated haemoglobin (HbA
findingsDiabetes prevalence among adults aged 45 years and older in India was 19·8% (95% CI 19·4-20·2), which amounted to 50·4 million people (49·4-51·4). Prevalence among men and women was similar (men, 19·6% [95% CI 19·0-20·2] and women, 20·1% [19·5-20·6]). Urban diabetes prevalence (30·0% [95% CI 29·1-30·8]) was approximately twice as high as rural prevalence (15·0% [14·6-15·5]). States with higher levels of economic development tended to have greater age-standardised prevalence (standardised regression coefficient for gross domestic product per capita 0·65 [95% CI 0·45-0·85]). Overall, 60·1% (59·0-61·2) of individuals were aware of their diabetes. Of individuals with diagnosed diabetes, 45·7% (44·3-47·2) achieved glycaemic control, 58·9% (57·5-60·4) achieved blood pressure control, and 6·4% (5·8-7·2) were taking a lipid-lowering medication.
interpretationOur findings emphasise the urgent need to scale up policies to better prevent, detect, manage, and control diabetes among middle-aged and older adults in India.
fundingUS National Institute on Aging; Ministry of Health and Family Welfare, Government of India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.